BALENTINE LLC – Vertex Pharmaceuticals Incorporated Transaction History
BALENTINE LLC portfolio value:
$2.52M
portfolio value
BALENTINE LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -19.83% | -2.15K shares | -539K | $289.54 | 8.70K |
| Q2 2022 | share | Increase | +333.88% | 8.35K shares | 2.40M | $281.79 | 10.86K |
| Q1 2022 | share | Increase | 0.00% | 2.50K shares | 653K | $260.97 | 2.50K |
| Q4 2020 | share | Decrease | -100.00% | -952 shares | -259K | $236.34 | 0 |
| Q3 2020 | share | Decrease | -1.96% | -19 shares | -23K | $272.12 | 952 |
| Q2 2020 | share | Increase | +5.31% | 49 shares | 63K | $290.31 | 971 |
| Q1 2020 | share | Increase | +58.69% | 341 shares | 92K | $237.95 | 922 |
| Q4 2019 | share | Increase | +96.28% | 285 shares | 77K | $218.95 | 581 |
| Q3 2019 | share | 0.00% | 0 shares | -4K | $169.42 | 296 | |
| Q2 2019 | share | Increase | +13.41% | 35 shares | 6K | $183.38 | 296 |
| Q1 2019 | share | 0.00% | 0 shares | 5K | $183.95 | 261 | |
| Q4 2018 | share | 0.00% | 0 shares | -7K | $165.71 | 261 | |
| Q3 2018 | share | Increase | 0.00% | 261 shares | 50K | $192.74 | 261 |
| Q1 2018 | share | Decrease | -100.00% | -649 shares | -97K | $162.98 | 0 |
| Q4 2017 | share | 0.00% | 0 shares | -2K | $149.86 | 649 | |
| Q3 2017 | share | Decrease | -23.29% | -197 shares | -10K | $152.04 | 649 |
| Q2 2017 | share | Decrease | -2.76% | -24 shares | 14K | $128.87 | 846 |
| Q1 2017 | share | 0.00% | 0 shares | 31K | $109.35 | 870 | |
| Q4 2016 | share | Increase | +37.01% | 235 shares | 9K | $73.67 | 870 |
| Q3 2016 | share | Increase | +392.25% | 506 shares | 44K | $87.21 | 635 |
| Q2 2016 | share | Increase | 0.00% | 129 shares | 11K | $86.02 | 129 |